ERCC1 and colorectal carcinoma: The same investigators (Park et al, 2003, Stoehlmacher et al, 2004) devised retrospective studies to determine the association between the ERCC1 codon 118 and 3′-UTR polymorphism and the clinical outcome of platinum-based chemotherapy in 106 patients with refractory advanced CRC.